Federation des caisses Desjardins du Quebec’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $537K | Sell |
3,116
-809
| -21% | -$150K | ﹤0.01% | 1239 |
|
|
2025
Q4 | $783K | Buy |
3,925
+596
| +18% | +$108K | ﹤0.01% | 1093 |
|
|
2025
Q3 | $521K | Buy |
3,329
+3,278
| +6,427% | +$521K | ﹤0.01% | 1218 |
|
|
2025
Q2 | $7.74K | Sell |
51
-100
| -66% | -$13.3K | ﹤0.01% | 2131 |
|
|
2025
Q1 | $22.7K | Sell |
151
-588
| -80% | -$98.6K | ﹤0.01% | 1691 |
|
|
2024
Q4 | $136K | Buy |
739
+312
| +73% | +$60.1K | ﹤0.01% | 1212 |
|
|
2024
Q3 | $84K | Buy |
427
+161
| +61% | +$33.5K | ﹤0.01% | 1304 |
|
|
2024
Q2 | $54.9K | Sell |
266
-111
| -29% | -$25.2K | ﹤0.01% | 1372 |
|
|
2024
Q1 | $94.2K | Buy |
377
+70
| +23% | +$16.7K | ﹤0.01% | 1255 |
|
|
2023
Q4 | $72.6K | Buy |
307
+15
| +5% | +$2.95K | ﹤0.01% | 1201 |
|
|
2023
Q3 | $57.2K | Sell |
292
-33
| -10% | -$6.78K | ﹤0.01% | 1273 |
|
|
2023
Q2 | $68.3K | Buy |
325
+152
| +88% | +$30.2K | ﹤0.01% | 1245 |
|
|
2023
Q1 | $34.9K | Sell |
173
-325
| -65% | -$73.7K | ﹤0.01% | 1424 |
|
|
2022
Q4 | $109K | Buy |
498
+51
| +11% | +$11.1K | ﹤0.01% | 1249 |
|
|
2022
Q3 | $88K | Sell |
447
-78
| -15% | -$16.8K | ﹤0.01% | 1357 |
|
|
2022
Q2 | $112K | Sell |
525
-21
| -4% | -$5.13K | ﹤0.01% | 1306 |
|
|
2022
Q1 | $155K | Hold |
546
| – | – | ﹤0.01% | 1220 |
|
|
2021
Q4 | $206K | Buy |
546
+76
| +16% | +$29.5K | ﹤0.01% | 1150 |
|
|
2021
Q3 | $194K | Sell |
470
-390
| -45% | -$162K | ﹤0.01% | 1176 |
|
|
2021
Q2 | $318K | Buy |
860
+564
| +191% | +$188K | ﹤0.01% | 1035 |
|
|
2021
Q1 | $85.8K | Buy |
296
+294
| +14,700% | +$81.7K | ﹤0.01% | 1389 |
|
|
2020
Q4 | $500 | Hold |
2
| – | – | ﹤0.01% | 2268 |
|
|
2020
Q3 | $453 | Buy |
+2
| New | +$415 | ﹤0.01% | 2083 |
|
|
2020
Q1 | – | Sell |
-1,478
| Closed | -$226K | – | 2252 |
|
|
2019
Q4 | $226K | Sell |
1,478
-7,166
| -83% | -$992K | ﹤0.01% | 1026 |
|
|
2019
Q3 | $1.14M | Sell |
8,644
-8,363
| -49% | -$1.12M | 0.02% | 607 |
|
|
2019
Q2 | $2.41M | Buy |
17,007
+1,700
| +11% | +$231K | 0.04% | 360 |
|
|
2019
Q1 | $2.22M | Sell |
15,307
-378
| -2% | -$49.7K | 0.03% | 366 |
|
|
2018
Q4 | $1.78M | Buy |
15,685
+378
| +2% | +$47.3K | 0.03% | 430 |
|
|
2018
Q3 | $2.06M | Hold |
15,307
| – | – | 0.03% | 448 |
|
|
2018
Q2 | $1.72M | Sell |
15,307
-921
| -6% | -$99.6K | 0.03% | 513 |
|
|
2018
Q1 | $1.73M | Sell |
16,228
-7,217
| -31% | -$778K | 0.03% | 494 |
|
|
2017
Q4 | $2.56M | Hold |
23,445
| – | – | 0.04% | 377 |
|
|
2017
Q3 | $2.54M | Hold |
23,445
| – | – | 0.04% | 368 |
|
|
2017
Q2 | $2.37M | Sell |
23,445
-6,175
| -21% | -$568K | 0.04% | 374 |
|
|
2017
Q1 | $2.66M | Buy |
+29,620
| New | +$2.52M | 0.05% | 292 |
|
Other funds holding CRL
VCM
VPM
Federation des caisses Desjardins du Quebec's CRL Position: Q1 2026 in Review
Federation des caisses Desjardins du Quebec reduced its Charles River Laboratories (CRL) stake by 21% in Q1 2026, selling an estimated $150K and leaving 3,116 shares worth $537K. The position accounts for ﹤0.01% of the portfolio, ranked #1239.
Federation des caisses Desjardins du Quebec first reported a position in CRL in Q1 2017 and has held it in 35 quarters since. The position peaked at $2.66M in Q1 2017. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.
- Federation des caisses Desjardins du Quebec held 3,116 shares of Charles River Laboratories worth $537K as of Q1 2026.
- Federation des caisses Desjardins du Quebec sold 809 Charles River Laboratories shares in Q1 2026, an estimated $150K.
- Charles River Laboratories made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #1239 holding.
- Federation des caisses Desjardins du Quebec first reported a position in Charles River Laboratories in Q1 2017 and has held it in 35 quarters since.
- Federation des caisses Desjardins du Quebec's Charles River Laboratories position peaked at $2.66M in Q1 2017.
- 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.
Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.